Top Markets
#1 DogBull DogBull +73.55%
#2 Siren Siren +31.86%
#3 OriginTrail OriginTrail +16.42%
#4 Verus Coin Verus Coin +9.51%
#5 MarsCoin MarsCoin +7.48%
#6 COTI COTI +6.57%
#7 Tutorial Tutorial +6.56%
#8 Falcon Finance Falcon Finance +6.28%
#9 PulseChain PulseChain +6.04%
#10 HOME HOME +5.95%
Coin of the day
DogBull DogBull
설정
언어
한국어
통화
USD
테마
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
주식 순위 #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
주가
$0.71707249
마지막 동기화: 2026-08-21
시가총액
$94.14M
변동 (1일)
-3.31%
변동 (1년)
76.82%
국가
SE
거래 AlzeCure Pharma AB (ALZCUR)

카테고리

Healthcare
AlzeCure Pharma AB (ALZCUR)의 매출
Aug 2026 기준 매출 TTM: 0
AlzeCure Pharma AB의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
AlzeCure Pharma AB의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH